Rohto Pharmaceutical Co Ltd 2024 Integrated Report
Company: Rohto Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 82
The report presents Rohto's record FY2023 performance, including consolidated net sales of 270.8 billion yen and 7,259 consolidated employees as of March 31, 2024. It describes Sustainability Targets 2030 covering GHG reduction, renewable electricity, waste, human capital, and safety. The report details a Sustainability Committee advising the Board and TCFD-related climate governance, while the displayed Scope 1 and 2 target and emissions data are identified as non-consolidated. Rohto also highlights global eye-health initiatives conducted in nine countries and regions during 2023.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.